Types of GLP-1-related medications The term "GLP-1 receptor agonists" typically refers to a class of injectable (or sometimes oral) drugs originally developed for Type 2 diabetes and now widely used for obesity/weight management
The simulations suggested that moving from weekly to every 14 days preserved about 70% of weight loss seen with weekly dosing, and even monthly dosing maintained roughly half of the effect
A prospective clinical trial conducted in India reported a significant decrease in LFC, but liver enzymes, liver stiffness, and pancreatic fat did not show statistically significant differences after 24 weeks of treatment with dulaglutide 1.5 mg in patients with MASLD and T2DM
Bone, sweet boneosteoporotic fractures in diabetes mellitus
Introduction to GLP-1 Agonists GLP-1 agonists have been pivotal in the pharmaceutical market for nearly two decades, beginning with the FDA approval of AstraZenecas Byetta in 2005
GLP-1 medications can help lower inflammation and support weight loss, both of which are important in PsA
